| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 32.92 Billion | USD 75.11 Billion | 8.6% | 2024 |
FrequentlyAsked Questions
The global diabetes care devices market is expected to grow due to rising prevalence of diabetes worldwide, coupled with technological advancements in monitoring and insulin delivery systems.
According to a study, the global diabetes care devices market size was worth around USD 32.92 Billion in 2024 and is expected to reach USD 75.11 Billion by 2034.
The global diabetes care devices market is expected to grow at a CAGR of 8.6% during the forecast period.
North America is expected to dominate the diabetes care devices market over the forecast period.
Leading players in the global diabetes care devices market include Terumo Corporation, Acon Laboratories Inc., Abbott Laboratories, Dexcom Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co. Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY Inc., Sanofi S.A.,, among others.
The report explores crucial aspects of the diabetes care devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients